Topics
Treatment, Diagnosis, Biology / Mechanism
Modality
Targeted therapy, Biomarker / Liquid biopsy, Imaging
Study type
Not listed
Abstract
Genomic profiling is used in the diagnosis, monitoring, and treatment of malignancies. Comprehensive genomic profiling (CGP) is a next-generation sequencing (NGS) approach that can test multiple genes simultaneously, potentially saving time, money, and sample material. Costs associated with genomic profiling could be a prohibitive…
Authors
Jamie P Grossman, Elizabeth A Sheppard, Zhuofan Yan, Magdalene Crabbe +1
AI-generated summary
Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology. reports: Genomic profiling is used in the diagnosis, monitoring, and treatment of malignancies. Comprehensive genomic profiling (CGP) is a next-generation sequencing (NGS) approach that can test multiple genes simultaneously, potentially saving time, money, and sample material. Costs associated with genomic profiling could be a prohibitive barrier to the widespread implementation of genomic testing in routine clinical practice.
This summary may be inaccurate. Verify with the primary paper.
Primary source: PubMed.